Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

• Egile Nagusiak: Nina Vodošek Hojs (Egilea), Sebastjan Bevc (Egilea), Robert Ekart (Egilea), Nejc Piko (Egilea), Tadej Petreski (Egilea), Radovan Hojs (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Diabetes mellitus is a global health issue and main cause of chronic kidney disease. Both diseases are also linked through high cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) is present in up to 40% of diabetic patients; therefore, prevention and treatment of DKD are of utmost...